Recognized Interpretive Criteria
Exceptions to the recognized standard of CLSI M100
Additional FDA-identified interpretive criteria
| 
			 Minimum Inhibitory  | 
			
			 Disk Diffusion  | 
		|||||
|---|---|---|---|---|---|---|
| 
			 Pathogen  | 
			
			 S  | 
			
			 I  | 
			
			 R  | 
			
			 S  | 
			
			 I  | 
			
			 R  | 
		
| 
			 Enterobacterales  | 
			
			 M100 standard is recognized  | 
		|||||
| 
			 Salmonella spp.  | 
			
			 M100 standard is recognized  | 
			
			 -  | 
			
			 -  | 
			
			 -  | 
		||
| 
			 Pseudomonas aeruginosa  | 
			
			 M100 standard is recognized  | 
		|||||
| 
			 Staphylococcus aureus (methicillin susceptible)  | 
			
			 ≤ 2  | 
			
			 4  | 
			
			 ≥ 8  | 
			
			 ≥ 16  | 
			
			 13-15  | 
			
			 ≤ 12  | 
		
| 
			 Haemophilus influenzae and parainfluenzae  | 
			
			 M100 standard is recognized  | 
		|||||
| 
			 Neisseria gonorrhoeae  | 
			
			 ≤ 0.25  | 
			
			 0.5-1  | 
			
			 ≥ 2  | 
			
			 ≥ 31  | 
			
			 25-30  | 
			
			 ≤ 24  | 
		
| 
			 Streptococcus pneumoniae  | 
			
			 M100 standard is recognized  | 
		|||||
| 
			 Streptococcus spp. β-Hemolytic Group  | 
			
			 M100 standard is recognized  | 
		|||||
S = Susceptible; I = Intermediate; R = Resistant
For the bacteria listed below, susceptibility test interpretive criteria are not recognized at this time:
Other Non-Entobacteriaceae
Streptococcus spp. Viridans Group